Issues

Herd immunity will not be a reality any time soon . . . if ever. That is according to the first national serological survey. Fewer than 10% of Americans… Read more

It’s another big week for Initial Public Offerings . . . With 13 private companies expected to go public. Palantir (private) will be the week’s biggest deal at a… Read more

The financial effects of the coronavirus pandemic are very real. The income earned by workers globally fell 10.7% cent in the first nine months of 2020, says the International… Read more

$22 billion. That’s the expected valuation of Palantir (private) when it goes public next week. Shares of the data-mining company could double on Day One  – just like Snowflake…. Read more

The fight between science and anti-science continues, as evidenced by vaccine news. The Food and Drug Administration (FDA) has quietly told vaccine makers to stick with the science. It… Read more

Apple is Warren Buffett’s #1 stock. And the Berkshire Hathaway (NYSE: BRK-B) Apple stake is now worth $109 billion! Yet Warren Buffett recently SOLD $800 million of Apple stock…. Read more

Will Trump approve the IPO of TikTok? YES. That’s according to Oracle (NYSE: ORCL) and TikTok’s Pre-IPO investors. Go here to discover the billionaire’s Pre-IPO secret. It’s the easy… Read more

I want to tell you a secret about coronavirus: “herd immunity” is a myth. This so-called strategy against coronavirus is a fancy term for doing next-to-nothing. Herd immunity means… Read more

AstraZeneca revealed details of its large coronavirus vaccine trials on Saturday. This followed similar steps from both Moderna and Pfizer. Scientists have been concerned about the AstraZeneca vaccine trials…. Read more